Assertio Therapeutics to Present at the 17th Annual Morgan Stanley Global Healthcare Conference
Assertio Holdings, Inc. (ASRT)
Last assertio holdings, inc. earnings: 3/9 04:02 pm
Check Earnings Report
Company Research
Source: GlobeNewswire
LAKE FOREST, Illinois, Aug. 20, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that members of senior management will participate at the 17th Annual Morgan Stanley Global Healthcare Conference in a session scheduled for 11:45 a.m. ET, Tuesday, September 10, 2019 in New York, NY. This presentation will be webcast and can be accessed via the Investor Relations page of the Assertio website at http://investor.assertiotx.com. Please access the website 15 minutes prior to the start of the call to download and install any necessary audio software. A recording of the webcast will be archived. About Assertio Therapeutics, Inc.Assertio Therapeutics is committed to providing responsible solutions to advance patient care in the Company’s core areas of neurology, orphan and specialty medicines. Assertio currently markets three FDA-approved products and continues to identify, license and develop new products that offer enhanced options for patients that may
Show less
Read more
Impact Snapshot
Event Time:
ASRT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ASRT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ASRT alerts
High impacting Assertio Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
ASRT
News
- Buxton Helmsley Calls for Senate Hearing on Well-Documented Evident Clinical Data Fraud at AssertioBusiness Wire
- Assertio Holdings, Inc. (NASDAQ: ASRT) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.MarketBeat
- Assertio Holdings Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]Yahoo! Finance
- Assertio Reports Third Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- Assertio Reports Third Quarter 2024 Financial ResultsGlobeNewswire
ASRT
Earnings
- 11/11/24 - Beat
ASRT
Sec Filings
- 11/19/24 - Form 4
- 11/15/24 - Form 4
- 11/14/24 - Form SCHEDULE
- ASRT's page on the SEC website